Cited by 391Phytoestrogen effects and researchNutritional Studies and DietCancer Risks and Factors

Soy, isoflavones, and breast cancer risk in Japan

Yamamoto, S., Sobue, T., Kobayashi, M., Sasaki, S., Tsugane, S.·2003·JNCI Journal of the National Cancer Institute

Abstract

Background Although isoflavones, such as those found in soy, have been shown to inhibit breast cancer in laboratory studies, associations between consumption of isoflavone-containing foods and breast cancer risk have been inconsistent in epidemiologic studies. We evaluated the relationship between isoflavone consumption and breast cancer risk among women in the Japan Public Health Center-Based Prospective Study on Cancer and Cardiovascular Diseases (JPHC Study). Methods In January 1990, 21 852 Japanese female residents (aged 40-59 years) from four public health center areas completed a self-administered questionnaire, which included items about the frequency of soy consumption. Through December 1999 and 209 354 person-years of follow-up, 179 women were diagnosed with breast cancer. Cox proportional hazards regression was used to estimate the relative risks (RRs) and 95% confidence intervals (CIs) for breast cancer in relation to consumption of miso soup, soyfoods, and estimated isoflavones. All statistical tests were two-sided. Results Consumption of miso soup and isoflavones, but not of soyfoods, was inversely associated with the risk of breast cancer. The associations did not change substantially after adjustment for potential confounders, including reproductive history, family history, smoking, and other dietary factors. Compared with those in the lowest quartile of isoflavone intake, the adjusted RRs for breast cancer for women in the second, third, and highest quartiles…

Integrity signals

Registry

Crossref · 10.1093/jnci/95.12.906

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Of 11 prospective cohort studies reporting on risk of primary breast cancer, one (9%) showed soy isoflavone intake was associated with overall reduced risk, while the remaining studies showed no associations.

    “Of 11 studies reporting on risk of primary breast cancer, one (9%) showed that soy isoflavone intake was associated with overall reduced risk of breast cancer [116], while the remaining studies showed no associations [99,104,105,107-109,111,113-115,117].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yamamoto, S., Sobue, T., Kobayashi, M., Sasaki, S., & Tsugane, S.
Affiliations
National Cancer Center Research Institute (JP)
Corresponding author
Yamamoto, S.
Venue
JNCI Journal of the National Cancer Institute
Published
2003-06-18
Volume
95
Issue
12
Pages
906-913
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2165986920
Cited by
391
References
1
Citations by year
2026: 4 · 2025: 10 · 2024: 7 · 2023: 10 · 2022: 10 · 2021: 14 · 2020: 16 · 2019: 6 · 2018: 13 · 2017: 15 · 2016: 15 · 2015: 13 · 2014: 19 · 2013: 17 · 2012: 15
FWCI
21.98
Type
journal article
Language
en
Open access
closed
Locations
  • JNCI Journal of the National Cancer Institute (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Phytoestrogen effects and research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
Keywords
breast cancer risk, isoflavones, soy consumption, miso soup, soy products, postmenopausal women, Japanese women, dietary intake, cancer prevention
MeSH terms
Adult, Breast Neoplasms, Feeding Behavior, Female, Humans, Isoflavones, Japan, Menopause, Middle Aged, Prospective Studies, Surveys and Questionnaires, Glycine max, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review